Japanese Kampo Medicine · Traditional Chinese Medicine
Goshajinkigan (Kidney Qi Pill)
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Goshajinkigan (Kidney Qi Pill) is a traditional Japanese Kampo formula containing ten herbs that primarily works through aconitine alkaloids and ginsenosides to support kidney yang energy. This multi-herb complex modulates the hypothalamic-pituitary-adrenal axis and enhances cellular energy metabolism through mitochondrial function improvement.
Goshajinkigan is a traditional Kampo formula known as the Kidney Qi Pill, used in Japanese medicine to support kidney function.
Some evidence from studies suggests Goshajinkigan may benefit kidney health and circulation, but more research is needed.
Goshajinkigan is typically taken in doses of 7.5 grams per day, often divided into smaller portions. Consult a healthcare provider before use.
Goshajinkigan (牛車腎気丸) is a traditional Kampo/TCM polyherbal formula, not a nutritional food, so macronutrient values (carbohydrates, protein, fat) are negligible at therapeutic doses. The formulation typically contains 10 crude herb components with the following key bioactive compounds and approximate concentrations per standard daily dose (typically 7.5 g of extracted granules or equivalent decoction): **Primary Herbal Components & Key Bioactives:** 1. **Rehmannia glutinosa (Jukujio/Shu Di Huang) ~5.0 g crude drug equivalent** – Catalpol (~0.3–0.5%), iridoid glycosides, rehmanniosides; supports renal and adrenal function. 2. **Cornus officinalis (Sanshyu/Shan Zhu Yu) ~3.0 g** – Loganin (~0.5–1.0%), morroniside, ursolic acid; antioxidant and anti-inflammatory. 3. **Dioscorea opposita (Sanyaku/Shan Yao) ~3.0 g** – Diosgenin (~0.1–0.3%), allantoin, polysaccharides; mild immunomodulatory activity. 4. **Alisma orientale (Takusha/Ze Xie) ~3.0 g** – Alisol A and B monoacetates (~0.2–0.5%), triterpenes; diuretic and lipid-modulating. 5. **Poria cocos (Bukuryo/Fu Ling) ~3.0 g** – Pachymic acid, polysaccharides (beta-glucans ~2–5%); immunomodulatory, mild anxiolytic. 6. **Paeonia suffruticosa (Botanpi/Mu Dan Pi) ~3.0 g** – Paeonol (~1.0–2.5%), paeoniflorin; anti-inflammatory, antiplatelet. 7. **Cinnamomum cassia (Keishi/Gui Zhi) ~1.0 g** – Cinnamaldehyde (~1–4%), cinnamic acid; vasodilatory, improves peripheral circulation. 8. **Aconitum carmichaelii (processed) (Bushi/Fu Zi) ~1.0 g** – Aconitine derivatives (hypaconitine, mesaconitine, reduced to <0.01% via processing); analgesic, thermogenic. 9. **Achyranthes bidentata (Goshitsu/Niu Xi) ~3.0 g** – Ecdysterone (~0.01–0.05%), oleanolic acid, saponins; promotes circulation to lower extremities, anti-inflammatory. 10. **Plantago asiatica (Shazenshi/Che Qian Zi) ~3.0 g** – Aucubin (~0.3–0.8%), plantaginin, dietary fiber (mucilage); mild diuretic, neuroprotective. **Micronutrients (trace amounts from crude herbs):** Potassium (~50–100 mg/dose), calcium (~20–40 mg), magnesium (~10–25 mg), iron (~2–5 mg), zinc (~1–3 mg), manganese (~0.5–1.5 mg). These are not primary nutritional sources. **Key Bioactive Compound Classes:** Iridoid glycosides (catalpol, loganin, aucubin), triterpene saponins (alisols, pachymic acid), phenylpropanoids (cinnamaldehyde, paeonol), polysaccharides (beta-glucans from Poria), and processed alkaloids (low-dose aconitine derivatives). **Bioavailability Notes:** Catalpol and loganin show moderate oral bioavailability (~20–30%). Paeonol is rapidly absorbed but extensively metabolized (half-life ~1–2 hours). Cinnamaldehyde has good oral absorption but rapid hepatic metabolism. Processed aconitine alkaloids have low but pharmacologically significant bioavailability. Polysaccharides from Poria and Dioscorea are partially fermented by gut microbiota, producing short-chain fatty acids that enhance systemic immunomodulatory effects. The polyherbal synergy is believed to enhance overall bioavailability through multi-target pharmacokinetic interactions. Caloric contribution per daily dose is negligible (<15 kcal).
Goshajinkigan's primary active compounds include aconitine from Aconiti Radix, ginsenosides from ginseng, and paeoniflorin from peony root. These compounds work synergistically to activate the renin-angiotensin system, enhance Na+/K+-ATPase activity in kidney tubules, and stimulate nitric oxide production for improved circulation. The formula also modulates inflammatory cytokines like TNF-α and IL-6 while supporting mitochondrial ATP synthesis through enhanced oxidative phosphorylation.
Clinical studies on goshajinkigan have primarily focused on diabetic neuropathy and chronic kidney conditions, with most trials involving 50-200 participants over 8-12 week periods. A randomized controlled trial of 132 diabetic patients showed 40% improvement in neuropathy symptoms compared to placebo after 12 weeks of treatment. Studies on chronic fatigue and lower urinary tract symptoms have shown modest benefits, though sample sizes remain relatively small (20-80 participants). The evidence is considered preliminary but promising, with most research conducted in Japan using standardized Kampo preparations.
Goshajinkigan is generally well-tolerated but can cause gastrointestinal upset, dizziness, or skin rash in sensitive individuals due to aconitine content. The formula may interact with diabetes medications by affecting blood glucose levels and should be used cautiously with diuretics or ACE inhibitors due to kidney-related effects. Pregnant and breastfeeding women should avoid this formula due to the presence of Aconiti Radix. Individuals with severe kidney disease, heart conditions, or hypertension should consult healthcare providers before use, as aconitine can affect cardiovascular function.
